Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 13, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 17, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001519419-26-000006
Filed / recorded
Mar 17, 2026, 8:08 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
GE HealthCare Technologies Inc.
Issuer CIK
1932393
Ticker
GEHC
Reporting person
Kevin Lobo
Relationship
Director
Security
Common Stock, par value $0.01 per share
Table
Non-derivative (Table I)
Transaction date
Mar 13, 2026
Transaction code
A
Shares / units
777
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
777
Ownership form
Direct
Amendment
No
Footnotes from the filing
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.